Log in

ISDE News

  • 26 Apr 2021 11:33 AM | ISDE Office (Administrator)

    As part of our ISDE 40th Anniversary celebration, you’ll read in upcoming months about each of the ISDE Congresses. This article summarizes the 7th and 8th ISDE World Congresses.

    The 7th ISDE World Congress was held in Montreal, Canada, in September 1998 (Figure 1). It was presided over by Prof. Andre Duranceau (Figure 2), who was to become ISDE President and Editor of Diseases of the Esophagus in future years. The organizing committee included Drs. Mulder, Beauchamp, Boivin, Mayrand, Colas, and Langevin. Special lectures were delivered by a number of world-renowned experts including F.G. Pearson, N.W. Diamant, D.O. Castell, J. Dent, S.J. Spechler, and D. Liebermann-Meffert. Thirty-nice countries were represented among a total of 538 registrants. The program focused on benign esophageal disease, including the broad topics of idiopathic reflux, Barrett’s, motor disorderes, esophageal cancer, and quality of life (Figure 3). A number of ISDE members were treated to a tour of Prof. Duranceau’s “cabane a sucre” (sugar cabin), a small wood structure nestled within a forest of maple trees, where he and his family distilled maple syrup that was among the finest quality in the world.

    The 8th ISDE World Congress took place in Sao Paulo, Brazil, in September 2001. This was ISDE’s first foray into the Southern Hemisphere and its first congress in the new millennium (Figure 4). The Congress President was Prof Henrique Pinotti (Figure 5), and the ISDE President was Tom DeMeester (Figure 6). Prof. Pinotti detailed in his presidential address the extent of benign esophageal diseases in South America, including Chagas’ disease (20 million affected), schistosomiasis affecting 3 million in Brazil with a frequent consequence of esophageal varices, and 25% of the population experiencing GERD. Over 600 abstracts were submitted from 33 different countries. The Congress was very well attended, having a large contingent of Japanese registrants as well as numerous physicians from South America, particularly the host country, Brazil (Figure 7). The latter country contributed nearly 200 presentations including oral abstracts, posters, and videos.

    Figure 1. The setting of the 7th ISDE World Congress in Montreal, Quebec, Canada.


    Figure 2. Professor Andre Duranceau, 7th ISDE World Congress President.


    Figure 3. The cover of the 7th ISDE World Congress program.


    Figure 4. Cover of the program of the 8th ISDE World Congress.


    Figure 5. Prof Henrique Walter Pinotti.

    Figure 6. ISDE President Tom DeMeester making introductory remarks during the 8th ISDE World Congress. To his right are Professors Ide, Watanabe, and Pinotti.


    Figure 7. Prof. Pinotti and guests (Mrs. Maruyama, Prof. Alberto Perrachia, Prof. Keiichi Maruyama) enjoying a reception during the 8th ISDE World Congress.

  • 13 Apr 2021 6:34 PM | ISDE Office (Administrator)

    We are pleased to introduce a new category of membership to the ISDE Community called the Associate Health Professional.

    Following our mission to Promote the exchange of scientific and medical knowledge of the esophagus among specialists in the field including physicians, surgeons, basic scientist, other health professionals and members of related industries, this new category welcomes non-physician and health professionals interested in the esophagus.

    The Associate Health Professional membership category appeals to the following professions: dieticians, nutritionists, health educators, medical scientists, nurses, nurse practitioners, pharmacists, PhD students, physician assistants, physical therapists/physiotherapists, physiologists, occupational therapists, researchers, speech pathologist, scientists, and speech therapists.

    Associate members will receive a number of benefits including access to the Diseases of the Esophagus Journal Issues and Supplements, discounts to the ISDE World Congress and other events, opportunity to serve on committees and task forces and access to member only content and services.

    There are two levels of Associate Health Professional membership available depending on where you live: Associate Health Professional (USD 75) and Associate Health Professional Developing Country (USD 50).

    We encourage you to share this exciting news with your colleagues, friends and any contacts who fit the criteria. Additional membership details can be found on the ISDE membership page.

    Have questions? Contact us at membership@isde.net.

  • 06 Apr 2021 2:03 PM | ISDE Office (Administrator)

    In observance of Esophageal Cancer Awareness month, review the following list of DOTE Esophageal Cancer articles:

  • 06 Apr 2021 2:02 PM | ISDE Office (Administrator)

    Throughout the month of April the ISDE Challenging Cases Facebook Group will be featuring esophageal cancer cases that frequently lead to therapeutic questions and discussions. Join the conversation and become a member of this group.

  • 06 Apr 2021 2:00 PM | ISDE Office (Administrator)

    Help us share the awareness of Esophageal Cancer by using the ISDE Esophageal Cancer Awareness Facebook frame.

    Need help setting this up? Let us know and we'll help you out, membership@isde.net.

  • 01 Apr 2021 4:20 PM | ISDE Office (Administrator)

    By Mindy Mintz Mordecai, CEO & Founder of Esophageal Cancer Action Network (ECAN)

    “If only we had known.” It’s refrain we hear too often from supporters of the Esophageal Cancer Action Network (ECAN). It’s the reason this non-profit patient advocacy organization was founded 12 years ago with a commitment to prevent the tragedy that has befallen too many families because they didn’t know that heartburn or acid reflux might lead to a life-threatening cancer.

    Lack of Awareness

    ECAN’s mission is to save lives – and one of the most important ways ECAN accomplishes its goal is by making more folks aware that persistent heartburn or reflux symptoms should not be taken lightly – that they may put their lives in danger. ECAN commissioned a poll by IPSOS to determine just how many Americans are aware of the link between reflux and cancer. The results were not surprising. Only 14% of Americans were aware that reflux disease could lead to cancer. Most of those surveyed could only point to heartburn as a symptom of reflux, with little understanding that symptoms like a hoarse voice, sore throat, persistent cough, or choking upon lying down could be signs of GERD. That’s why ECAN continues its relentless efforts to increase awareness about Esophageal Cancer.

    Proclamations in the Halls of Power

    Even though Esophageal Adenocarcinoma was the fastest increasing cancer diagnosis in the United States back in 2009, it did not receive much attention nor research funding. That’s why ECAN started Esophageal Cancer Awareness Month in 2009 with the first Gubernatorial proclamation coming from the state of Maryland. Since then, nearly every state in the nation has declared April Esophageal Cancer Awareness Month at least once over the past 12 years. Possibly even more important, the media, business entities, hospitals, and governmental and professional groups reach out in April to raise awareness about Esophageal Cancer and its link to reflux disease.

    Sharing Information

    In 2021, ECAN is making it easy for citizens to educate everyone they know with opportunities to share important awareness messages about Esophageal Cancer. Among those opportunities are lawn signs you can order to post in your own yard, and ECAN’s Text-a-Day service. Participants in the free texting program will receive a text every day during the month of April with easily sharable social media posts, videos, stories, and infographics that they can share with their friends and family - providing a potentially life-saving message every day during Esophageal Cancer Awareness Month. Those opportunities for individuals to raise awareness can be found at ECAM2021.org.

    Increasing Research Funding

    April is also an important time for those advocating on Capitol Hill. For ECAN, it’s when our advocacy campaign to include Esophageal Cancer in the multi-million-dollar Peer-Reviewed Cancer Research Program (PRCRP) of the U.S. Dept. of Defense is heating up! For the past two years, ECAN and its supporters have successfully convinced Congress to include Esophageal Cancer in this important program. In 2021, the result will be more than $4 million in additional research funding for Esophageal Cancer. Before ECAN’s efforts, Esophageal Cancer researchers were not included in the program except in years when they accepted applications for research into rare cancers. You can find out more about the research funding available this year through the PRCRP at ec-research.org.

    Taking Steps to Save Lives

    More than 400 supporters of the fight to end Esophageal Cancer are expected to participate in ECAN’s second Virtual Steps to Save Lives 5K Run, Walk or Roll from April 18 – 25th! Anyone anywhere can participate and ECAN will send those who register a great “swag bag” with a medal, racing bib, t-shirt, and lots of awareness materials to share along with some other little gifts.

    The 5K competition is run on an honor system. Runners who win in their respective age and gender categories will receive medals and overall winners get crystal awards. Fundraisers earn nice prizes as they work toward their goals and top fundraising individuals and teams get very special prizes. But fundraising is not required to participate. You can get all the details and register at StepstoSaveLives.org.

    Lighting the Night Sky in Periwinkle

    ECAN is also working to raise public awareness about Esophageal Cancer as it gets iconic buildings and landmarks to be illuminated in periwinkle blue (Esophageal Cancer’s awareness color) during the month of April. Locations such as NASCAR’s Headquarters and the Niagara Falls are among the sites that will share that awareness raising light again this year.

    First Esophageal Cancer Conference for All Stakeholders

    Though not strictly in April, ECAN is putting the finishing touches on plans for the first Esophageal Cancer Virtual Collaborative Conference for All Stakeholders called GERD, Barrett’s Esophagus & Esophageal Cancer: A Path to Save Lives to be held in May of this year. The conference is focused on collaboration between healthcare professionals, patients, caregivers, advocates and industry.

    The three-day virtual conference has an illustrious panel of presenters with a robust schedule of topics, including:

    • Detection and Treatment of Barrett’s Esophagus,
    • Familial Links in Barrett’s Esophagus,
    • An In-Depth Look at Personalized Medicine in Esophageal Cancer,
    • A Point-Counterpoint on the Benefits of Esophagectomy,
    • Collaborative Session addressing the dramatic increase in Early-Onset Esophageal Adenocarcinoma.

    The agenda includes a focus on the needs of survivors of Esophageal Cancer, morning yoga sessions, lunchtime cooking demonstrations and even some entertainment from an Esophageal Cancer survivor who has performed Off-Broadway.

    At the conference, ECAN will also present its first Bogart Awards to an individual, a researcher, and lawmakers who have made extraordinary contributions to the wellbeing of those at risk for Esophageal Cancer. Humphrey Bogart died of Esophageal Cancer in 1956 and his Estate has had a partnership with ECAN for nearly a decade. You can sign up for more information about the conference at APathtoSaveLives.org.

    Reward of Raising Awareness

    ECAN’s goal is that one day a repeat survey of Americans can be conducted and will show a much-increased understanding among the general public about the risks posed by persistent Gastroesophageal Reflux Disease. Just as we all know the importance of sunscreen to head off skin cancer, ECAN is working toward the day when everybody understands that reflux disease is not a mere annoyance so they get the medical attention they need to avoid ever having to say, “If only we had known.”

  • 31 Mar 2021 1:16 PM | ISDE Office (Administrator)

    The European Society for Diseases of the Esophagus (ESDE) and the International Gastric Cancer Association European Chapter (IGCA), will be holding their first joint Congress from November 18 -20, 2021 in Milan, Italy. A series of webinars will be held ahead of the congress between April to September and the first three topics and dates are as follows:

    Esophageal motor disorders and new diagnostic advancements. Do treatments improve - April 22

    Stage 4 gastric cancer. A road map to an European consensus - May 27

    Update and future perspectives of ongoing clinical trials - June 24

    Find out more on the ESDE IGCA Joint congress website.

  • 31 Mar 2021 1:14 PM | ISDE Office (Administrator)

    Comparison of Esophagectomy outcomes between a National Center, a National Audit Collaborative, and an International database using the Esophageal Complications Consensus Group (ECCG) standardized definitions
    DOTE Featured Article
    Members Only Access

    The ECCG developed a standardized platform for reporting operative complications, with consensus definitions. The Dutch Upper Gastrointestinal Cancer Audit (DUCA) published a national comparison against these benchmarks. This study compares ECCG data from the Irish National Center (INC) with both published benchmark studies. All patients undergoing multimodal therapy or surgery with curative intent from 2014 to 2018 inclusive were studied, with data recorded prospectively and entered onto a secure online database (Esodata.org). Read the full Comparison of Esophagectomy outcomes between a National Center article.

  • 31 Mar 2021 1:11 PM | ISDE Office (Administrator)

    Effect of anastomotic leaks on long-term survival after oesophagectomy for oesophageal cancer: systematic review and meta-analysis
    DOTE Volume 34, Issue 3 | Editor's Choice
    Free Article

    Long-term survival after curative surgery for oesophageal cancer surgery remains poor, and the prognostic impact of anastomotic leak (AL) remains unknown. A meta-analysis was conducted to investigate the impact of AL on long-term survival. Read the full Effect of anastomotic leaks on long-term survival article for free.

    Abandoning resectional intent in patients initially deemed suitable for esophagectomy: a nationwide study of risk factors and outcomes
    DOTE Volume 34, Issue 3 | Editor's Choice
    Free Article

    The main curative treatment modality for esophageal cancer is resection. Patients initially deemed suitable for resection may become unsuitable, most commonly due to signs of generalized disease or having become unfit for surgery. The aim was to assess risk factors for abandoning esophagectomy and its impact on survival. All patients diagnosed with an esophageal or gastroesophageal junction cancer in the Swedish National Register for Esophageal and Gastric Cancer from 2006–2016 were included and risk factors associated with becoming ineligible for resection were analyzed in multivariable logistic regression analysis. Read the full Abandoning resectional intent in patients article for free.

  • 31 Mar 2021 1:11 PM | ISDE Office (Administrator)

    Review a collection of the top ten articles from recent years and stay up-to-date on research that’s making the largest impact in the field, including the following:

    • Comparison of short-term outcomes between robot-assisted minimally invasive esophagectomy and video-assisted minimally invasive esphagectomy in treating middle thoracic esophageal cancer
    • Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer – a narrative review
    • Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esphagus or gastroesophageal junction: long-term results of a randomized clinical trial
    • Economic and survival burden of dysphagia among inpatients in the United States
    • The 2018 ISDE achalasia guidelines

    Checkout the reading list online for the complete list.

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software